Literature DB >> 19048007

Inflammation, glucocorticoids and risk of cardiovascular disease.

Frank Buttgereit1, Gerd-Rüdiger Burmester, Brian J Lipworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19048007     DOI： 10.1038/ncprheum0963

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  10 in total

1.  Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease.

Authors:  Igor Karp; Michal Abrahamowicz; Gillian Bartlett; Louise Pilote
Journal:  Am J Epidemiol       Date:  2004-10-01       Impact factor: 4.897

Review 2.  Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.

Authors:  Frank Buttgereit; Rainer H Straub; Martin Wehling; Gerd-Rüdiger Burmester
Journal:  Arthritis Rheum       Date:  2004-11

3.  Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial.

Authors:  Glenn Haugeberg; Anders Strand; Tore K Kvien; John R Kirwan
Journal:  Arch Intern Med       Date:  2005-06-13

Review 4.  Cardiovascular disease in rheumatoid arthritis.

Authors:  Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2006-05       Impact factor: 5.006

Review 5.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

6.  Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Authors:  P C Souverein; A Berard; T P Van Staa; C Cooper; A C G Egberts; H G M Leufkens; B R Walker
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

7.  Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk.

Authors:  H G Raterman; V P van Halm; A E Voskuyl; S Simsek; B A C Dijkmans; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2007-06-08       Impact factor: 19.103

8.  Glucocorticoid receptor gene and risk of cardiovascular disease.

Authors:  Erica L T van den Akker; Jan W Koper; Elisabeth F C van Rossum; Marieke J H Dekker; Henk Russcher; Frank H de Jong; Andre G Uitterlinden; Albert Hofman; Huibert A Pols; Jacqueline C M Witteman; Steven W J Lamberts
Journal:  Arch Intern Med       Date:  2008-01-14

9.  Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?

Authors:  Igor Karp; Michal Abrahamowicz; Paul R Fortin; Louise Pilote; Carolyn Neville; Christian A Pineau; John M Esdaile
Journal:  Arthritis Rheum       Date:  2008-02-15

Review 10.  Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

Authors:  J R Kirwan; J W J Bijlsma; M Boers; B J Shea
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24
  10 in total
  6 in total

1.  Prednisone prevents particle induced bone loss in the calvaria mouse model.

Authors:  Michael M Schündeln; Jakob Höppner; Felix L Meyer; Wiebke Schmuck; Max D Kauther; Gero Hilken; Bodo Levkau; Martina Rauner; Corinna Grasemann
Journal:  Heliyon       Date:  2021-08-18

2.  Dexamethasone, tetrahydrobiopterin and uncoupling of endothelial nitric oxide synthase.

Authors:  Silke Tobias; Alice Habermeier; Daniel Siuda; Gisela Reifenberg; Ning Xia; Ellen I Closs; Ulrich Förstermann; Huige Li
Journal:  J Geriatr Cardiol       Date:  2015-09       Impact factor: 3.327

Review 3.  The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response.

Authors:  Nina Dedic; Alon Chen; Jan M Deussing
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

4.  Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome.

Authors:  Wei-Chih Chen; Kuo-Chin Kao; Chau-Chyun Sheu; Ming-Cheng Chan; Yu-Mu Chen; Ying-Chun Chien; Chung-Kan Peng; Shinn-Jye Liang; Han-Chung Hu; Ming-Ju Tsai; Wen-Feng Fang; Wann-Cherng Perng; Hao-Chien Wang; Chieh-Liang Wu; Kuang-Yao Yang
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

Review 5.  [Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis].

Authors:  Gernot Keyßer
Journal:  Z Rheumatol       Date:  2021-03-11       Impact factor: 1.372

6.  Autoimmune rheumatic diseases.

Authors:  Juan-Manuel Anaya; Yehuda Shoenfeld; Frank Buttgereit; Miguel A Gonzalez-Gay
Journal:  Biomed Res Int       Date:  2014-08-05       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.